Eric I Richman insider trades
Eric I Richman has filed 12 Form 4s with the SEC that we hold, for Gain Therapeutics, Inc. (GANX) (Director) and NBSE (Director). Across all of them we count 9 purchases worth $109.2K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 4,922 shares of Gain Therapeutics, Inc. worth $38.7K, dated 2021-08-16. The first filing on our record is dated 2021-08-17 and the latest 2025-06-25.
Gain Therapeutics, Inc. (GANX)
Director · 9 filings · 6 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2021-08-16 | P, purchase reported on Form 4 | 4,922 | $38.7K | 2022-04-21 | SEC |
| 2022-05-19 | P, purchase reported on Form 4 | 4,000 | $10.8K | 2022-05-23 | SEC |
| 2022-05-20 | P, purchase reported on Form 4 | 9,256 | $26.2K | 2022-05-23 | SEC |
| 2022-05-25 | P, purchase reported on Form 4 | 2,482 | $6.4K | 2022-05-27 | SEC |
| 2024-07-01 | P, purchase reported on Form 4 | 5,000 | $6.2K | 2024-07-01 | SEC |
| 2024-07-01 | P, purchase reported on Form 4 | 12,000 | $14.5K | 2024-07-01 | SEC |
NBSE
Director · 3 filings · 3 purchases and sales
Source
Counted from the Form 4 filings this reporting owner (SEC CIK 1313876) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
